Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy

被引：30

作者：

Mocroft, A

Gatell, J

Reiss, P

Ledergerber, B

Kirk, O

Vella, S

Blaxhult, A

Phillips, AN

Lundgren, J

机构：

[1] Royal Free Centre for HIV Medicine, Dept. of Prim. Care and Pop. Sci., Roy. Free and Univ. Coll. Med. Sch., London

[2] Hospital Clinic Universitari, Barcelona

[3] Acad. Medisch Ctr. Univ. Amsterdam, Amsterdam

[4] University Hospital, Zürich

[5] Copenhagen HIV Program, Hvidovre Hospital, Copenhagen

[6] Istituto Superiore di Sanita, Rome

[7] Karolinska Hospital, Stockholm

来源：

AIDS | 2004年 / 18卷 / 17期

关键词：

D O I：

10.1097/00002030-200411190-00018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Studies have shown an increased risk of new AIDS/death among injecting drug users (IDU) starting highly active antiretroviral therapy (HAART). Of 3872 patients starting HAART in the EuroSIDA study, 819 were IDU (21.2%). During 14 769 person-years of follow-up, 499 patients progressed to new AIDS/death. Compared with homosexual individuals, IDU had an increased incidence of new AIDS/death, but only for non-HIV deaths. There is an urgent need to define and standardize causes of death in observational studies.

引用

页码：2333 / 2337

页数：5

共 5 条

[1]

Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8

[2] Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].

Egger, M ;

May, M ;

Chêne, G ;

Phillips, AN ;

Ledergerber, B ;

Dabis, F ;

Costagliola, D ;

Monforte, AD ;

de Wolf, F ;

Reiss, P ;

Lundgren, JD ;

Justice, AC ;

Staszewski, S ;

Leport, C ;

Hogg, RS ;

Sabin, CA ;

Gill, MJ ;

Salzberger, B ;

Sterne, JAC .

LANCET, 2002, 360 (9327) :119-129

[3]

Mocroft A, 1999, J ACQ IMMUN DEF SYND, V22, P369

[4] Decline in the AIDS and death rates in the EuroSIDA study: an observational study [J].

Mocroft, A ;

Ledergerber, B ;

Katlama, C ;

Kirk, O ;

Reiss, P ;

Monforte, AD ;

Knsyz, B ;

Dietrich, M ;

Phillips, AN ;

Lundgren, JD .

LANCET, 2003, 362 (9377) :22-29

[5] CLINICAL MANIFESTATIONS AND PREDICTORS OF DISEASE PROGRESSION IN DRUG-USERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

SELWYN, PA ;

ALCABES, P ;

HARTEL, D ;

BUONO, D ;

SCHOENBAUM, EE ;

KLEIN, RS ;

DAVENNY, K ;

FRIEDLAND, GH .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24) :1697-1703

← 1 →